BRIEF-iBio – IBIO-610 Plus Semaglutide Preserves Lean Mass In Eight-Week Obese NHP Study

4

Oct 13 (Reuters) – iBio Inc: * IBIO – IBIO-610 PLUS SEMAGLUTIDE PRESERVES LEAN MASS IN EIGHT-WEEK OBESE NHP STUDY * IBIO – IBIO-610 DEMONSTRATES 97% REDUCTION IN ACTIVE ACTIVIN E AT WEEK 8 IN NHP

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)